Drug for refractory psoriatic arthritis shows promise in clinical trial

Patients with psoriatic arthritis for whom standard-of-care pharmaceutical treatments have provided no lasting relief experienced a significant reduction in symptoms, including joint tenderness and swelling, have reported promising results when they were given a new drug.

Leave a Reply

Your email address will not be published. Required fields are marked *